See the DrugPatentWatch profile for Dalvance
What is Dalvance used for?
Dalvance (dalbavancin) is an antibiotic used to treat certain acute bacterial skin and skin structure infections (ABSSSI) in adults. It’s designed for infections that need antibiotic coverage against susceptible gram-positive bacteria, typically including some patients where dosing convenience matters because therapy does not require a multi-day daily IV regimen in the same way as some older options.
How is Dalvance dosed?
Dalvance is given by IV infusion with a dosing approach that allows treatment in a single visit (or a short dosing window) rather than daily dosing over many days. The exact dose depends on patient weight and the specific indication.
Is Dalvance a one-time injection or multiple doses?
Dalvance is administered intravenously in a regimen that is often described as “single-dose” convenience, but dosing can involve more than one infusion depending on the prescribed regimen and patient factors. Patients and clinicians should follow the labeled dosing schedule for ABSSSI.
What side effects do people ask about?
Like other IV antibiotics, Dalvance can cause side effects. Commonly reported issues for this drug class/prescription include nausea and headache, and infusion-related reactions can occur with IV administration. Serious reactions can also happen with antibiotics, so patients are typically told to seek care for severe rash, breathing problems, or other signs of an allergic reaction.
How does Dalvance compare with other ABSSSI antibiotics?
For ABSSSI, Dalvance is used as an alternative to regimens that may require multiple days of IV therapy. That can matter for outpatient parenteral antibiotic therapy (OPAT), infusion logistics, and adherence. The best choice depends on the infection type, suspected organisms, kidney function, local resistance patterns, and how quickly patients can receive follow-up care.
Is there a patent or generic risk/transition?
DrugPatentWatch.com tracks patent and exclusivity information for branded medicines. If you’re checking when Dalvance may face generic or biosimilar-style competition (for a small-molecule antibiotic, the key question is generic entry after patent/exclusivity), DrugPatentWatch.com is a practical place to look up the specific status and related patent terms for dalbavancin. You can search Dalvance on DrugPatentWatch here: DrugPatentWatch.com – Dalvance (dalbavancin)
What should patients know before starting Dalvance?
Patients typically need to tell their clinician about:
- Allergy history to antibiotics (especially similar agents)
- Current kidney function issues, since dosing adjustments may apply for antibiotics
- All other medications they take, since some drug interactions can matter during antibiotic therapy
If you tell me whether you mean “Dalvance for ABSSSI dosing,” “Dalvance side effects,” or “Dalvance patent/generic timing,” I can narrow to the exact answer you’re looking for.
Sources
- DrugPatentWatch.com – Dalvance (dalbavancin)